APA (7th ed.) Citation

Klotz, L. V., Casjens, S., Johnen, G., Taeger, D., Brik, A., Eichhorn, F., . . . Weber, D. G. (2024). Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients. Lung cancer, 192, . https://doi.org/10.1016/j.lungcan.2024.107802

Chicago Style (17th ed.) Citation

Klotz, Laura Valentina, et al. "Combination of Calretinin, MALAT1, and GAS5 as a Potential Prognostic Biomarker to Predict Disease Progression in Surgically Treated Mesothelioma Patients." Lung Cancer 192 (2024). https://doi.org/10.1016/j.lungcan.2024.107802.

MLA (9th ed.) Citation

Klotz, Laura Valentina, et al. "Combination of Calretinin, MALAT1, and GAS5 as a Potential Prognostic Biomarker to Predict Disease Progression in Surgically Treated Mesothelioma Patients." Lung Cancer, vol. 192, 2024, https://doi.org/10.1016/j.lungcan.2024.107802.